Skip to content

Medroxyprogesterone

Published: July 26, 2026Updated: July 26, 2026

Medroxyprogesterone acetate is a synthetic progestin hormone administered as an injectable suspension for long-acting contraception. It works by suppressing gonadotropin release, which prevents ovulation and thickens cervical mucus to block sperm penetration. This medication is primarily used in women of reproductive age who desire reversible birth control.

Quick summary

Medroxyprogesterone is an injectable hormonal contraceptive that prevents pregnancy by stopping ovulation and thickening cervical mucus.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
G03AC06
RxNorm
6691
Generic
Medroxyprogesterone
Class
atc-g03
Brands
Depo-Provera, Provera, depo-subQ provera
Availability
rx
Lactation
unknown
Routes
oral
Forms
prefilled syringe, injection, suspension, tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: No specific toxic threshold established; doses up to 2000 mg have been reported without life-threatening effects
Chronic overdose: Prolonged use at high doses may lead to adrenal suppression, osteoporosis, and cardiovascular effects
Immediate actions
Supportive care, monitor vital signs, gastric decontamination if ingestion is recent
Antidote
No specific antidote available(N/A - supportive care is the primary treatment)
Poison Control: 1-800-222-1222

Special Populations

10 groups
✗

pregnancy

first trimester
unsafe
FDA Category
X
Dose Adjustment

avoid completely

Key Recommendations

contraindicated for use as contraceptive in pregnancy; if pregnancy occurs during treatment, discontinue immediately

Monitor

confirm pregnancy status before initiating therapy

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

second trimester
unsafe
FDA Category
X
Dose Adjustment

avoid completely

Key Recommendations

discontinue if pregnancy is confirmed; contraindicated for contraceptive use

Monitor

regular prenatal monitoring if exposure occurred

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
D
Dose Adjustment

avoid completely

Key Recommendations

do not use; may cause fetal abnormalities and complicate labor

Monitor

fetal monitoring if exposure occurred

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
unsafe
FDA Category
N
Dose Adjustment

discontinue breastfeeding or avoid drug

Key Recommendations

medroxyprogesterone passes into breast milk; not recommended during lactation

Monitor

monitor infant for effects of progestin exposure

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

no specific adjustment required

Key Recommendations

use with caution; consider cardiovascular and thromboembolic risk factors

Monitor

regular assessment of cardiovascular status and bone density

Use with caution and monitor for adverse effects.

⚠

pediatric_age

adolescents
caution
FDA Category
X
Dose Adjustment

not recommended for contraception in adolescents

Key Recommendations

may be used for approved indications in post-menarchal females; consider bone health with long-term use

Monitor

monitor bone mineral density with prolonged use in adolescents

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

no dosage adjustment typically required

Key Recommendations

use with caution; monitor renal function periodically

Monitor

periodic assessment of renal function

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe
caution
FDA Category
N
Dose Adjustment

use lowest effective dose

Key Recommendations

use with caution; limited clinical data in severe impairment

Monitor

close monitoring of renal function and adverse effects

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild
caution
FDA Category
N
Dose Adjustment

no standard adjustment; use caution

Key Recommendations

metabolized in liver; monitor for adverse effects

Monitor

monitor liver function tests

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

moderate to severe
contraindicated
FDA Category
X
Dose Adjustment

do not use

Key Recommendations

contraindicated in known or suspected hepatic malignancy, active liver disease, or jaundice

Monitor

not applicable - avoid use

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:Progestin

Medroxyprogesterone is a synthetic progestin hormone

usageFDA
2023

Common uses

Value:Contraception, menstrual disorders, endometrial hyperplasia

Primary therapeutic applications

prescribingFDA
2023

FDA approval year (Depo-Provera)

Value:1992

Contraceptive injection approval

prescribingFDA
2023

FDA approval year (Provera oral)

Value:1978

Oral formulation approval

Long-acting reversible contraception in women of reproductive age, and secondary amenorrhea treatment

Inhibits gonadotropin secretion, preventing follicular maturation and ovulation while thickening cervical mucus to impede sperm passage

Administered as an intramuscular injection; fertility may not return immediately after discontinuation; not recommended during pregnancy; common side effects include menstrual changes, weight gain, and mood changes. Requires healthcare provider administration.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy